Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
08/2003
08/26/2003US6610716 Cyanomethyl substituted thiazoliums and imidazoliums and treatments of disorders associated with protein aging
08/26/2003US6610715 Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same
08/26/2003US6610713 Treating cell with cholinergic agonist
08/26/2003US6610700 Inhibit binding of integrins to their ligands, use in immune or inflammatory disorders; 3-(4-((2,6-Naphthyridinyl)amino)-phenyl)-2-((2-(1-ethylpropyl)-3-oxo-1 -cyclopentenyl) amino)-propionic acid, for example
08/26/2003US6610698 Treatment of tumor necrosis factor-alpha, interleukin-1 beta, interleukin-6, and interleukin-8 mediated diseases
08/26/2003US6610697 Substituted 2-aryl-3-(heteroaryl)-imidazo[1,2-a]pyrimidines, and related pharmaceutical compositions and methods
08/26/2003US6610695 Prophylaxis or treatment of CSBP/RK/p38 kinase mediated disease
08/26/2003US6610687 Benzofuranylsulfonates
08/26/2003US6610683 Treatment of infectious disease using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitors
08/26/2003US6610674 Method of treating inflammatory conditions with progesterone analogs
08/26/2003US6610665 2-(purin-9-yl)-tetrahydrofuran-3, 4-diol derivatives
08/26/2003US6610523 Human mitogen-activated (MAP) kinase kinase isoforms (MKKs). MKKs mediate unique signal transduction pathways that activate human MAP kinases p38 and JNK, which result in activation of other factors, including activating
08/26/2003US6610324 Analgesics; rheumatic diseases; muscular disorders; sleep disorders
08/26/2003US6610294 Methods of inhibiting an autoimmune response in a human suffering from an autoimmune disease by administering an antibody that binds to a protein to which monoclonal antibody 5C8 binds
08/26/2003US6610284 Preparation for prevention and healing of inflammation affections
08/25/2003CA2405347A1 Medicament comprising nk4 gene or recombinant nk4 protein
08/21/2003WO2003068954A2 Microorganism for genetic therapeutic treatment of proliferative diseases
08/21/2003WO2003068946A1 Phenalenone derivatives, method for the production thereof and use of the same
08/21/2003WO2003068937A2 Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells
08/21/2003WO2003068813A2 Group b streptococcus antigen
08/21/2003WO2003068812A2 Immune-modulating peptide made of s. aureus enterotoxin b
08/21/2003WO2003068811A2 Cytotoxic t-cell epitopes from chlamydia
08/21/2003WO2003068803A2 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
08/21/2003WO2003068768A1 Imidazole 4-carboxamide compounds with adenosine deaminase inhibiting activity
08/21/2003WO2003068766A1 1-phenyl-2-heteroaryl-substituted benzimidazole derivatives, the use thereof for producing drugs used in the treatment of immunological diseases
08/21/2003WO2003068760A2 Compounds possessing affinity at 5ht1-type receptors and use thereof in therapy of cns disorders
08/21/2003WO2003068759A1 Piperazine derivatives as anti-inflammatory agents
08/21/2003WO2003068754A1 Therapeutic substituted indazole derivatives
08/21/2003WO2003068750A1 Jnk inhibitor
08/21/2003WO2003068749A1 Vanilloid receptor modulators
08/21/2003WO2003068747A1 Nicotinamide derivates useful as p38 inhibitors
08/21/2003WO2003068746A1 Aryl ureas as kinase inhibitors
08/21/2003WO2003068744A1 Pyridine derivatives or salts thereof and cytokine production inhibitors containing the same
08/21/2003WO2003068743A1 Chemical compounds
08/21/2003WO2003068264A1 New medicinal compositions on the basis of anticholinergic agents and egfr kinase inhibitors
08/21/2003WO2003068258A1 7s immunoglobulin for treatment of choroidal neovascularisation_
08/21/2003WO2003068250A1 Compositions and methods for treatment of skin disorders
08/21/2003WO2003068239A1 Novel drugs for external use
08/21/2003WO2003068237A1 Beta-sheet mimetics and composition and methods relating thereto
08/21/2003WO2003068235A1 Nicotinamide derivatives useful as pde4 inhibitors
08/21/2003WO2003068234A1 Nicotinamide derivatives and a tiotropium salt in combination for the treatment of e.g. inflammatory, allergic and respiratory diseases
08/21/2003WO2003068233A1 Nicotinamide derivatives and a tiotropium salt in combination for the treatment of e.g. inflammatory, allergic and respiratory diseases
08/21/2003WO2003068232A1 Nicotinamide derivatives useful as pde4 inhibitors
08/21/2003WO2003068230A1 Substituted pyridinones as modulators of p38 map kinase
08/21/2003WO2003068229A1 Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors
08/21/2003WO2003068228A1 Aryl ureas with angiogenesis inhibiting activity
08/21/2003WO2003068225A1 Microglia inhibitors for interrupting immune reactions induced by interleukin 12 and ifn$g(g)
08/21/2003WO2003068224A2 Use of inhibitors of the sodium-dependent chloride-bicarbonate-exchanger for treating thrombotic and inflammatory diseases
08/21/2003WO2003068212A1 Use of sodium/hydrogen exchange inhibitors from the treatment of thrombotic and inflammatory diseases
08/21/2003WO2003068204A1 Synthesis of substituted sulfonyl amines
08/21/2003WO2003068203A1 Use of a combination of a non-steroidal anti-inflammatory agent and guaifenesin for the treatment of acute pain
08/21/2003WO2003068202A1 Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies
08/21/2003WO2003068197A1 Method for systemic drug delivery through the nail
08/21/2003WO2003068196A1 Colonic release composition
08/21/2003WO2003068171A2 Method and composition for treatment of inflammation and aids-associated neurological disorders
08/21/2003WO2003068166A2 Treatment of ophthalmic disorders using urea and urea derivatives
08/21/2003WO2003068146A2 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases
08/21/2003WO2003068140A2 Novel pyridazine derivatives, use of the same as medicaments, pharmaceutical compositions and method for producing the same
08/21/2003WO2003067991A1 Compositions and methods for treatment of microbial infections
08/21/2003WO2003055913A3 Secreted protein
08/21/2003WO2003037254A3 Methods and compositions for the treatment and diagnosis of pain disorders using 46566
08/21/2003WO2003027075A3 Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation
08/21/2003WO2003024935A3 Substituted pyrazolyl compounds for the treatment of inflammation
08/21/2003WO2003024474A3 Anti-inflammatory agent
08/21/2003WO2003020751A3 Homing peptides
08/21/2003WO2003007930A3 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors
08/21/2003WO2002088664A3 Control of compactability through crystallization
08/21/2003WO2002085384A3 Lubricious coatings for substrates
08/21/2003WO2002062999A3 Proteins and nucleic acids encoding same
08/21/2003WO2002057452A3 Human proteins, polynucleotides encoding them and methods of using the same
08/21/2003WO2002046158A3 Piperidine/piperazine-type inhibitors of p38 kinase
08/21/2003WO2002044209A3 Cytonkine receptor zcytor19
08/21/2003WO2002036611A3 Immunomodulatory peptides derived from heat shock proteins and uses thereof
08/21/2003WO2002036573A3 8- substituted-2, 6-methano-3-benzazocines and 3-substituted morphinanes as opioid receptor binding agents
08/21/2003WO2002020722A9 Methods and compositions for in vitro targeting
08/21/2003WO2002010392A9 Mammalian dna binding membrane-associated protein-encoding gene and uses
08/21/2003WO2001079479A3 Methods for selective targeting
08/21/2003US20030158413 A thiochromane-7-carboxamide derivatives as Rho kinase enzyme inhibitor; nontoxic, anticancer agents
08/21/2003US20030158409 Pyridine derivatives inhibiting angiogenesis and/or vegf receptor tyrosine kinase
08/21/2003US20030158399 Compositions and methods for the treatment and diagnosis of immune disorders
08/21/2003US20030158376 Relaxin-like factor and methods and uses thereof
08/21/2003US20030158266 Particularly septic shock
08/21/2003US20030158252 Especially trypsin-like serine proteases, such as chymotrypsin, trypsin, thrombin, plasmin and factor Xa.
08/21/2003US20030158250 Agents correcting gene expression regulatory error
08/21/2003US20030158242 Salt with a sugar substitute, especially saccharin, cyclamate or acesulfame.
08/21/2003US20030158238 Treating diseases such as cancer, inflammatory disorders, restenosis,
08/21/2003US20030158225 Novel compounds
08/21/2003US20030158205 N-benzyl-substituted, e.g., (2S)-1-(p-chlorophenoxy)methyl)-carbonyl-2-methyl-4-(p -fluorobenzyl)piperazine; inhibit the activity of the chemokines, MIP-1 alpha and RANTES
08/21/2003US20030158204 Diamino phenothiazine derivatives and composition comprising same
08/21/2003US20030158197 Certain alkylene diamine-substituted heterocycles
08/21/2003US20030158195 1,6 naphthyridines useful as inhibitors of SYK kinase
08/21/2003US20030158192 Activating cytokine biosynthesis, viricides treating a viral disease, antitumor agents, immunomodulators
08/21/2003US20030158189 Non-steroidal antiinflammatory agents treating bone disorders, Crohn's disease, and inflammatory bowel disease, respiratory disorders such as chronic obstructive pulmonary disease, infections, autoimmune diseases
08/21/2003US20030158187 Genetic polymorphisms in the preprotachy kinin gene
08/21/2003US20030158185 Novel use of phenylheteroakylamine derivatives
08/21/2003US20030158173 NK 1 antagonists
08/21/2003US20030158163 Conversion of carboxylic acid substituent in a gonane ring, into the methyl ester, or hydrochlorination of a 9-11-epoxy-9-H-cyclopenta(a)phenanthrene compounds
08/21/2003US20030158147 Method for treating pain
08/21/2003US20030158125 Polysaccharidic esters of n-derivatives of glutamic acid
08/21/2003US20030158099 Cancer therapy
1 ... 817 818 819 820 821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 ... 1272